Characterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancer
about
Cell cycle- and cancer-associated gene networks activated by Dsg2: evidence of cystatin A deregulation and a potential role in cell-cell adhesionCrosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis.PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.Effects of publicly funded and quality of life on attendance rate among methadone maintenance treatment patients in Taiwan: an 18-month follow-up study.Ultra-sensitive detection of brain-derived neurotrophic factor (BDNF) in the brain of freely moving mice using an interdigitated microelectrode (IME) biosensor.Pinin facilitated proliferation and metastasis of colorectal cancer through activating EGFR/ERK signaling pathway.c-Src/Cav1-dependent activation of the EGFR by Dsg2150th Anniversary Series: Desmosomes and the Hallmarks of Cancer.Pathophysiology of the Desmo-Adhesome.Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth.Effect of purified fractions from cell culture supernate of high-density pre-B acute lymphoblastic leukemia cells (ALL3) on the growth of ALL3 cells at low density.Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes.
P2860
Q35192319-4E3ADD43-3D68-4281-BFDE-3B3687EDFA53Q35832178-5EA272E6-EB1C-4500-BF1C-AA32B6D698BAQ36023904-772ED3DF-286E-4C77-8F58-D9DA5AB637D4Q36169169-E1D676C6-A810-42B2-B73A-93373AC079BFQ37264014-C3C88798-B8F8-4265-8761-19BD27A7947AQ37301846-5A622836-B2F3-47F8-83B5-786112103469Q37437211-39AB4BCF-4162-4CF7-A271-FAEE5F98F2E5Q38541665-7D222A01-B5B4-4F70-B89D-37DAC546C6E2Q38922797-3ECE5856-2E59-4BCE-A0E6-B3994401D008Q39388818-AE75D3F7-C22C-41EE-86E6-40A87FCB4DD8Q42280031-220087CB-CE49-42E2-A3E6-EF1EFE82D758Q49798718-85AE4C73-8C5F-41E9-9818-F72214C33161Q50203153-BBFA5680-6A12-4012-B75C-FEBFB921E375
P2860
Characterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancer
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Characterization of desmoglein ...... for aggressive prostate cancer
@ast
Characterization of desmoglein ...... for aggressive prostate cancer
@en
Characterization of desmoglein ...... for aggressive prostate cancer
@nl
type
label
Characterization of desmoglein ...... for aggressive prostate cancer
@ast
Characterization of desmoglein ...... for aggressive prostate cancer
@en
Characterization of desmoglein ...... for aggressive prostate cancer
@nl
prefLabel
Characterization of desmoglein ...... for aggressive prostate cancer
@ast
Characterization of desmoglein ...... for aggressive prostate cancer
@en
Characterization of desmoglein ...... for aggressive prostate cancer
@nl
P2093
P2860
P3181
P1433
P1476
Characterization of desmoglein ...... for aggressive prostate cancer
@en
P2093
Alison G Barber
Angela M Christiano
Benjamin A Rybicki
Dennis M Bonal
Mireia Castillo-Martin
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0098786
P407
P577
2014-01-01T00:00:00Z